Article History
Received: 3 April 2020
Revised: 23 April 2020
Accepted: 27 April 2020
First Online: 11 May 2020
Compliance with ethical standards
:
: SAP: research funding to the institution from Pharmacyclics, MorphoSys, Janssen, Astra Zeneca, TG Therapeutics, Bristol Myers Squibb, AbbVie, and Ascentage Pharma. Advisory Board compensation to the institution from: Pharmacyclics, AstraZeneca, Genentech, Gilead, GlaxoSmithKline, Verastem Oncology, and AbbVie. NEK: research funding to the institution from Acerta Pharma, Bristol Myers Squibb, Pharmacyclics, Tolero Pharmaceuticals, MEI Pharma Abbvie and Sunesis. Data Safety Monitoring Committee (DSMC) for Agios Pharm, AstraZeneca, Cytomyx Therapeutics, and Rigel. Advisory Board for Cytomx Therapy, Pharmacyclics, Juno Therapeutics, Astra Zeneca, and Oncotracker. The other author declare that he has no conflict of interest.